| Budget Amount *help |
¥18,460,000 (Direct Cost: ¥14,200,000、Indirect Cost: ¥4,260,000)
Fiscal Year 2011: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2009: ¥9,100,000 (Direct Cost: ¥7,000,000、Indirect Cost: ¥2,100,000)
|
|---|
| Research Abstract |
BLT1-deficient mice exhibited milder symptoms in models of osteoporosis, multiple sclerosis and spinal injury, suggesting the possible application of BLT1 antagonists in these diseases. We established BLT2-deficient mice, and found that BLT2 protects intestinal inflammation by enhancing the barrier functions of colon epithelial cells. We established a system to measure 12-HHT, a BLT2 ligand in combination of liquid chromatography and mass spectrometry.
|
